Literature DB >> 1572183

Gastric colonization and pneumonia in intubated critically ill patients receiving stress ulcer prophylaxis: a randomized, controlled trial.

N M Apte1, D R Karnad, T P Medhekar, G H Tilve, S Morye, G G Bhave.   

Abstract

OBJECTIVE: To study the effects of pharmacologically increasing gastric pH on gastric colonization and the development of pneumonia in intubated critically ill patients.
DESIGN: Randomized, controlled trial.
SETTING: Medical ICU in a university hospital. PATIENTS: Thirty-four tracheotomized patients with tetanus.
INTERVENTIONS: Sixteen patients received iv ranitidine to increase gastric pH greater than 4 (ranitidine group), while 18 patients received no prophylaxis for upper gastrointestinal bleeding (control group).
MEASUREMENTS AND MAIN RESULTS: Mean gastric pH was higher in the ranitidine group (median 4.7, range 3.6 to 6.1) than in the control group (median 2.1, range 1.2 to 4.9; p less than .05). Gastric colonization occurred in 15 (94%) of 16 patients who received ranitidine, 2 days (median; range 1 to 5) after intubation; gastric colonization also occurred in all control patients (median 4 days, range 1 to 9; p less than .05). Pneumonia occurred in 13 (81%) of 16 patients who received ranitidine, 3 days (median, range 1 to 5) after intubation and in nine (50%) of 18 control patients (p less than .01) 5 days after tracheal intubation (median, range 3 to 14; p less than .01). Prior gastric colonization by the pathogen that caused pneumonia was demonstrable in nine (56%) of 16 patients who received ranitidine vs. eight (44%) of 18 control patients (p greater than .05). The risk for developing pneumonia in the ranitidine-treated group was highest in the first 4 days after tracheal intubation. There was no difference in the frequency of upper gastrointestinal hemorrhage in the two groups.
CONCLUSIONS: Pharmacologically increasing gastric pH increases the risk for developing pneumonia in intubated critically ill patients. The pneumonia occurs earlier than in untreated control patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1572183     DOI: 10.1097/00003246-199205000-00008

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  21 in total

Review 1.  Prevention of nosocomial bacterial pneumonia.

Authors:  J L Vincent
Journal:  Thorax       Date:  1999-06       Impact factor: 9.139

Review 2.  Association between proton pump inhibitors and respiratory infections: a systematic review and meta-analysis of clinical trials.

Authors:  Nabil Sultan; Jose Nazareno; James Gregor
Journal:  Can J Gastroenterol       Date:  2008-09       Impact factor: 3.522

Review 3.  Histamine H2-receptor antagonists in peptic ulcer disease. Evidence for a prophylactic use.

Authors:  J Nash; L Lambert; M Deakin
Journal:  Drugs       Date:  1994-06       Impact factor: 9.546

4.  Pharmacoeconomic analysis of stress ulcer prophylaxis for critically ill patients.

Authors:  G T Schumock; N P Lam; S R Winkler; S X Kong
Journal:  Pharmacoeconomics       Date:  1996-05       Impact factor: 4.981

Review 5.  Nosocomial pneumonia in pediatric patients: practical problems and rational solutions.

Authors:  Heather J Zar; Mark F Cotton
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 6.  Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis.

Authors:  Chun-Sick Eom; Christie Y Jeon; Ju-Won Lim; Eun-Geol Cho; Sang Min Park; Kang-Sook Lee
Journal:  CMAJ       Date:  2010-12-20       Impact factor: 8.262

Review 7.  Risk of fracture and pneumonia from acid suppressive drugs.

Authors:  Chun-Sick Eom; Sang-Soo Lee
Journal:  World J Methodol       Date:  2011-09-26

8.  Prevalence and outcome of gastrointestinal bleeding and use of acid suppressants in acutely ill adult intensive care patients.

Authors:  Mette Krag; Anders Perner; Jørn Wetterslev; Matt P Wise; Mark Borthwick; Stepani Bendel; Colin McArthur; Deborah Cook; Niklas Nielsen; Paolo Pelosi; Frederik Keus; Anne Berit Guttormsen; Alma D Moller; Morten Hylander Møller
Journal:  Intensive Care Med       Date:  2015-04-10       Impact factor: 17.440

Review 9.  Intracerebral hemorrhage specific intensity of care quality metrics.

Authors:  Adnan I Qureshi
Journal:  Neurocrit Care       Date:  2011-04       Impact factor: 3.210

10.  Stress ulcer prophylaxis with proton pump inhibitors or histamin-2 receptor antagonists in adult intensive care patients: a systematic review with meta-analysis and trial sequential analysis.

Authors:  Marija Barbateskovic; Søren Marker; Anders Granholm; Carl Thomas Anthon; Mette Krag; Janus Christian Jakobsen; Anders Perner; Jørn Wetterslev; Morten Hylander Møller
Journal:  Intensive Care Med       Date:  2019-01-24       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.